Dr. Brian Pierson, MD
NPI: 1780767319
Total Payments
$10,984
2023 Payments
$21.91
Companies
52
Transactions
497
Medicare Patients
1,469
Medicare Billing
$269,231
Payment Breakdown by Category
Food & Beverage$7,123 (64.9%)
Consulting$3,500 (31.9%)
Travel$347.88 (3.2%)
Education$12.80 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,123 | 489 | 64.9% |
| Consulting Fee | $3,500 | 1 | 31.9% |
| Travel and Lodging | $347.88 | 2 | 3.2% |
| Education | $12.80 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| kaleo, Inc. | $4,019 | 7 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $653.71 | 51 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $589.74 | 43 | $0 (2022) |
| ABBVIE INC. | $440.47 | 24 | $0 (2022) |
| Sentynl Therapeutics, Inc. | $379.12 | 33 | $0 (2019) |
| Egalet US Inc | $347.07 | 50 | $0 (2018) |
| Amgen Inc. | $319.13 | 16 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $278.92 | 16 | $0 (2020) |
| ASSERTIO THERAPEUTICS, Inc. | $260.40 | 18 | $0 (2019) |
| PFIZER INC. | $253.49 | 25 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $21.91 | 1 | Boston Scientific Corporation ($21.91) |
| 2022 | $688.65 | 37 | ABBVIE INC. ($177.09) |
| 2021 | $616.28 | 40 | AbbVie Inc. ($229.64) |
| 2020 | $231.80 | 14 | Supernus Pharmaceuticals, Inc. ($54.73) |
| 2019 | $1,165 | 81 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($210.25) |
| 2018 | $1,967 | 152 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($277.52) |
| 2017 | $6,293 | 172 | Kaleo, Inc. ($4,007) |
All Payment Transactions
497 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/15/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/18/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Gastroenterology | ||||||
| 09/15/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Gastroenterology | ||||||
| 09/01/2022 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Analgesic | ||||||
| 08/31/2022 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Genetic Disease | ||||||
| 08/29/2022 | PROTEGA PHARMACEUTIALS LLC | Roxybond (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Pan Management | ||||||
| 08/16/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Migraine | ||||||
| 08/10/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: Gastroenterology | ||||||
| 08/08/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: Gastroenterology | ||||||
| 08/03/2022 | Hikma Pharmaceuticals USA | Kloxxado (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 07/28/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.09 | General |
| Category: Opioid Analgesic | ||||||
| 07/25/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $24.27 | General |
| Category: Endocrinology | ||||||
| 07/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Gastroenterology | ||||||
| 06/21/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2022 | UPSHER-SMITH LABORATORIES LLC | TOSYMRA (Drug), ZEMBRACE SYMTOUCH | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: NEUROLOGY | ||||||
| 06/06/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Neuroscience | ||||||
| 06/06/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Gastroenterology | ||||||
| 05/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: Gastroenterology | ||||||
| 05/19/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: PRIMARY CARE | ||||||
| 04/21/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Pain Management | ||||||
| 04/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 670 | 1,225 | $296,015 | $97,113 |
| 2021 | 4 | 361 | 1,048 | $139,568 | $88,521 |
| 2020 | 4 | 438 | 1,280 | $163,380 | $83,597 |
Total Patients
1,469
Total Services
3,553
Medicare Billing
$269,231
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 377 | $101,790 | $38,867 | 38.2% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2022 | 190 | 460 | $55,200 | $13,295 | 24.1% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 48 | 54 | $39,960 | $13,183 | 33.0% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 53 | 61 | $36,295 | $12,000 | 33.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 106 | 134 | $28,140 | $8,236 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 90 | $16,650 | $6,384 | 38.3% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 15 | 19 | $9,880 | $2,938 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $6,450 | $2,026 | 31.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 15 | $1,650 | $185.69 | 11.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 172 | 502 | $80,320 | $53,862 | 67.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 149 | 407 | $48,850 | $29,661 | 60.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 32 | $8,800 | $4,905 | 55.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 16 | 107 | $1,598 | $92.13 | 5.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 202 | 764 | $91,680 | $49,092 | 53.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 193 | 391 | $62,560 | $31,947 | 51.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 25 | 28 | $7,700 | $2,457 | 31.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 18 | 97 | $1,440 | $101.63 | 7.1% |
About Dr. Brian Pierson, MD
Dr. Brian Pierson, MD is a Preventive Medicine/Occupational Environmental Medicine healthcare provider based in Exton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780767319.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Pierson, MD has received a total of $10,984 in payments from pharmaceutical and medical device companies, with $21.91 received in 2023. These payments were reported across 497 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($7,123).
As a Medicare-enrolled provider, Pierson has provided services to 1,469 Medicare beneficiaries, totaling 3,553 services with total Medicare billing of $269,231. Data is available for 3 years (2020–2022), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Preventive Medicine/Occupational Environmental Medicine
- Other Specialties Pain Medicine
- Location Exton, PA
- Active Since 10/24/2006
- Last Updated 12/14/2021
- Taxonomy Code 2083P0500X
- Entity Type Individual
- NPI Number 1780767319
Products in Payments
- Evzio (Drug) $4,007
- RELISTOR ORAL (Drug) $468.32
- RELISTOR (Drug) $376.19
- UBRELVY (Drug) $346.89
- Aimovig (Biological) $301.45
- Levorphanol (Drug) $301.04
- Xtampza ER (Drug) $277.47
- AIMOVIG (Biological) $243.36
- NURTEC ODT (Drug) $232.39
- BUNAVAIL 2.1 mg 30-count box (Drug) $227.21
- ZOHYDRO ER (Drug) $217.58
- ARYMO ER (Drug) $207.52
- XTAMPZA (Drug) $203.47
- TROKENDI XR (Drug) $196.58
- LYRICA (Drug) $190.42
- Morphabond ER (Drug) $163.48
- Cambia (Drug) $161.38
- VRAYLAR (Drug) $150.03
- Horizant (Drug) $131.31
- Amitiza (Drug) $129.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.